ESC 365 - Drug-eluting devices versus angioplasty in infrapopliteal artery disease:an updated systematic review and meta-analysis

ESC Premium Access

Drug-eluting devices versus angioplasty in infrapopliteal artery disease:an updated systematic review and meta-analysis

Session: Cardiovascular treatment: protecting the brain and the limbs

Topic: Intervention

Speaker: Mr E. Katsuyama (Santo Andre, BR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Mr Eric Katsuyama

Faculty of Medicine of ABC, Santo Andre (Brazil)

0 follower

4 more presentations in this session

Remnant cholesterol, not LDL cholesterol, explains peripheral artery disease risk conferred by apolipoprotein B: a cohort study

Speaker: Doctor B. Nilsson Wadstrom (Copenhagen, DK)

The evolution of carotid atherosclerotic plaque composition: a prospective study

Speaker: Mr L. Zuo (Rotterdam, NL)

Extracranial systemic embolic events in patients with atrial fibrillation: an individual patient-level meta-analysis of 71 683 patients randomized to NOAC vs warfarin from the COMBINE-AF study

Speaker: Doctor S. Al Said (Boston, US)

The influence of concomitant antiplatelet therapy in venous thromboembolism patients treated with anticoagulants in the DOAC era: insight from the COMMAND VTE Registry-2

Speaker: Doctor K. Kaneda (Kyoto, JP)

Access the full session

Cardiovascular treatment: protecting the brain and the limbs

Speakers: Mr E. Katsuyama, Doctor B. Nilsson Wadstrom, Mr L. Zuo, Doctor S. Al Said, Doctor K. Kaneda

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources